TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0

Historical Portfolio Holders from Q1 2022 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 2.250% 3/0
Principal, excl. options Q1 2024
271 M
Holdings value Q1 2024
$212 M
Value change Q1 2024
-$34.1 B
Grand Portfolio weight change Q1 2024
-0.071%
Number of holders
17
Number of buys Q1 2024
7
Number of sells Q1 2024
-7
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.325%
CUSIP
89422GAA5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $271 M $212 M -$34.1 B $0.63 17
2023 Q4 $307 M $202 M +$19.5 M $0.66 17
2023 Q3 $274 M $208 M -$7.12 M $0.65 21
2023 Q2 $295 M $262 M -$151 K $0.81 21
2023 Q1 $304 M $330 M +$7.32 M $0.98 21
2022 Q4 $294 M $290 M -$17 M $0.91 23
2022 Q3 $279 M $291 M -$119 K $1.02 23
2022 Q2 $285 M $697 M -$20.4 M $1.00 25
2022 Q1 $302 M $748 M +$748 M $1.06 25